BackI-Mab Overview

I-Mab Current Assets

Latest current assets for IMAB: $170M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$167.64M
↓ 27.26% YoYΔ $-62.84M vs prior year quarter

Peer trimmed avg / median

Loading

I-Mab Current Assets History

Loading

I-Mab vs. peers: Current Assets Comparison

Loading

I-Mab Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

I-Mab (IMAB) FAQ

The latest current assets for IMAB is $170M as of June 2025. That compares with $230M in the prior-year period — down 27.3% year over year. Investors often review this figure alongside I-Mab's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMAB's current assets moved from $230M to $170M — a 27.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in I-Mab's operating scale or balance-sheet position.

A current assets figure of $170M for IMAB is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMAB's current assets ($170M), review year-over-year change from $230M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack I-Mab's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.